Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?

by Halton Jacqueline, Nagel Kim, Brandão Leonardo R, Silva Mariana, Gibson Paul, Chan Anthony, Blyth Kay, Hicks Kim, Parmar Nagina, Paddock Leslie, Willing Stephanie, Thabane Lehana, Athale Uma
Published 2012-07-01